- Home
- SUPV vs ARDX Comparison
SUPV vs ARDX Comparison
Compare SUPV & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPV
- ARDX
- Stock Information
- Founded
- SUPV 1887
- ARDX 2007
- Country
- SUPV Argentina
- ARDX United States
- Employees
- SUPV N/A
- ARDX N/A
- Industry
- SUPV Commercial Banks
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- SUPV Finance
- ARDX Health Care
- Exchange
- SUPV Nasdaq
- ARDX Nasdaq
- Market Cap
- SUPV 844.8M
- ARDX 882.9M
- IPO Year
- SUPV 2016
- ARDX 2014
- Fundamental
- Price
- SUPV $9.97
- ARDX $4.33
- Analyst Decision
- SUPV Buy
- ARDX Strong Buy
- Analyst Count
- SUPV 2
- ARDX 9
- Target Price
- SUPV $17.00
- ARDX $10.17
- AVG Volume (30 Days)
- SUPV 1.1M
- ARDX 3.9M
- Earning Date
- SUPV 08-13-2025
- ARDX 08-04-2025
- Dividend Yield
- SUPV 1.88%
- ARDX N/A
- EPS Growth
- SUPV N/A
- ARDX N/A
- EPS
- SUPV 0.13
- ARDX N/A
- Revenue
- SUPV $742,986,958.00
- ARDX $361,706,000.00
- Revenue This Year
- SUPV $30.41
- ARDX $10.10
- Revenue Next Year
- SUPV $40.48
- ARDX $32.38
- P/E Ratio
- SUPV $16.26
- ARDX N/A
- Revenue Growth
- SUPV N/A
- ARDX 127.33
- 52 Week Low
- SUPV $5.00
- ARDX $3.21
- 52 Week High
- SUPV $19.75
- ARDX $7.18
- Technical
- Relative Strength Index (RSI)
- SUPV 43.29
- ARDX 52.98
- Support Level
- SUPV $9.52
- ARDX $4.21
- Resistance Level
- SUPV $11.19
- ARDX $4.47
- Average True Range (ATR)
- SUPV 0.53
- ARDX 0.18
- MACD
- SUPV 0.14
- ARDX -0.04
- Stochastic Oscillator
- SUPV 28.69
- ARDX 41.46
About SUPV Grupo Supervielle S.A. each Representing five Class B shares
Grupo Supervielle SA offers financial products & services. The company's segments include Personal and Business Banking, Corporate Banking, Bank Treasury, Consumer Finance, Insurance, and Asset Management and other services. The company provides services to individuals, small businesses, middle-market companies, and large corporates in Argentina. The company also offers mutual fund services.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.